中外製薬【4519】 希薄化後一株あたり利益の推移

機能の使い方
(単位:円) 希薄化後一株あたり利益 前年比(%)
1Q26 70.13 +18.7%
4Q25 78.02 +40.2%
3Q25 67.58 +1.6%
2Q25 59.04 -13.2%
1Q25 59.08 +30.7%
4Q24 55.64 +0.4%
3Q24 66.53 +41.1%
2Q24 67.98 +34.5%
1Q24 45.21 +1.2%
4Q23 55.43 -11.0%
3Q23 47.14 +14.4%
2Q23 50.56 +14.9%
1Q23 44.67 -44.2%
4Q22 62.28 +3.7%
3Q22 41.2 -21.2%
2Q22 43.99 +2.3%
1Q22 80.09 +177.9%
4Q21 60.08 +89.0%
3Q21 52.28 +43.0%
2Q21 42.99 +39.4%
1Q21 28.82 -69.3%
4Q20 31.79 +30.2%
3Q20 36.55 -
2Q20 30.85 -
1Q20 93.99 -
4Q19 24.42 -